HOYA Surgical Optics Risk Report

⚖️ legal & regulatory

Hoya Surgical Optics has been involved in legal proceedings, with a settlement reached in a patent suit related to cataract treatment technology. This suggests a proactive approach to resolving disputes in the competitive medical equipment industry, which might stem from underlying patent challenges or innovations within the sector.

• Hoya and Alcon settled a patent suit over cataract treatment technology 🗓 February 20, 2024.

🏗️ operational & business continuity

Hoya Surgical Optics faced operational challenges recently due to a cyber incident. Such events can disrupt production and have significant impacts on business continuity if not addressed swiftly. Companies in the medical equipment manufacturing sector need to ensure robust cybersecurity measures are in place to prevent similar issues in the future.

• A cyber incident affected Hoya's production, highlighting operational risks 🗓 April 4, 2024.

📜 innovation & r&d

Hoya Surgical Optics is actively engaged in innovation and research, focusing on developing solutions to improve cataract surgery outcomes and intraocular lens technology. Their commitment to R&D is evident through several initiatives, including a new research center in Singapore, contributing to advancements in eyecare technology.

• Hoya launched a new global research and development center in Singapore to tackle the global cataract burden 🗓 September 25, 2020.
• A randomized multicenter trial assessed posterior capsule opacification and glistenings in hydrophobic acrylic intraocular lenses 🗓 February 17, 2023.
• Video analysis explored optic-haptic interaction during intraocular lens implantation 🗓 December 19, 2023.
• Research into hydrophobic acrylic intraocular lenses addressed changes according to temperature and hydration 🗓 October 14, 2020.